Six-year outcomes of a phase II study of human-tissue engineered blood vessels for peripheral arterial bypass

Piotr Gutowski,Malgorzata Guziewicz,Marek Ilzecki,Arkadiusz Kazimierczak,Jeffrey H Lawson,Heather L Prichard,Stanislaw Przywara,Rabih Samad,William Tente,Jakub Turek,Wojcieh Witkiewicz,Norbert Zapotoczny,Tomaz Zubilewicz,Laura E Niklason

JVS-Vascular Science（2023）

引用 6|浏览23

暂无评分

摘要

The infection-resistant, off-the-shelf HAV could provide a durable alternative conduit in the arterial circuit setting to restore the lower extremity blood supply in patients with PAD, with remodeling into the recipient's own vessel over time. The HAV is currently being evaluated in seven clinical trials to treat PAD, vascular trauma, and as a hemodialysis access conduit.

查看译文

关键词

Arterial reconstruction,Bioengineered blood vessel,Human acellular vessel,Long-term outcomes,Peripheral artery disease

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要